Results 111 to 120 of about 7,220 (213)

Prurigo nodularis

The Tohoku Journal of Experimental Medicine, 1951
openaire   +3 more sources

Treatment of immunotherapy-associated pruritus and prurigo nodularis refractory to dupilumab with nemolizumab. [PDF]

JAAD Case Rep
Luo AJ, Rajabi F, Kashaf S, Leventhal JS.   +3 more
europepmc   +1 more source

The State of the Art in Chronic Prurigo Nodularis. [PDF]

Dermatol Ther (Heidelb)
Serra-Baldrich E, Flórez Á, Julià Manresa M, Ortiz de Frutos FJ, Pereyra-Rodriguez JJ, Pérez B, Figueras I.   +6 more
europepmc   +1 more source

Novel intralesional nemolizumab for chronic scalp prurigo nodularis. [PDF]

JAAD Case Rep
Gaven E, Siddiqui S, Stout M.
europepmc   +1 more source

Chronic prurigo in an adolescent patient successfully controlled with dupilumab. [PDF]

Skin Health Dis
Al-Abdulla MN, Al-Qahtani N, Younis SM, Rizvi S, Elfaieg A, Buddenkotte J, Steinhoff M.   +6 more
europepmc   +1 more source

Bullous prurigo pigmentosa

, 2006
Prurigo pigmentosa is a rare inflammatory skin disease of unknown etiology, characterized by recurrent, symmetrical, pruritic, erythematous papules resulting in gross reticular hyperpigmentation. The rash occurs mainly on the back, the chest and the nape
DE FRANCESCO V, PATRONE, Pasquale, QUINKENSTEIN E, FRATTASIO A, PILLON B, MARIUZZI, Laura   +5 more
core  

Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case Series. [PDF]

Cureus
Chakravadhanula U, Nagarajan M, Bhat S.
europepmc   +1 more source

Nemolizumab is associated with improved sleep duration and fewer nocturnal awakenings in patients with prurigo nodularis. [PDF]

JAAD Int
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

Prurigo Nodularis [PDF]

Proceedings of the Royal Society of Medicine, 1928
openaire   +4 more sources

Use of dupilumab in the management of refractory prurigo nodularis in an immunosuppressed double transplanted patient. [PDF]

An Bras Dermatol
Valenzuela Godoy D, Agüero R, Kolbach M.   +2 more
europepmc   +1 more source